We have observed
4 EP applications
Inger Margrethe Schelde Madsen
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after February 24, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
NEW POLYMORPHIC FORM OF A CALCIMIMETIC COMPOUND
[1,2,4]TRIAZOLOPYRIDINES AND THEIR USE AS PHOSPODIESTERASE INHIBITORS
BENZODIOXOLE DERIVATIVES AS PHOSPHODIESTERASE INHIBITORS